Global Alzheimer?s Disease Drug Market Study 2015-2025, by Segment (Donepezil, Memantine, Rivastigmine), by Market (Early to Moderate Stages, Moderate to Severe StagesMemantine), by Company (Lundbeck., Merz Pharma, Eisai)
ReportPage
Report ID
50466
Published Date
17-Sep
No of Report Page
72
Report Category
Medical Devices
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
    
The global Alzheimer?s Disease Drug market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
    
Product Type Coverage (Market Size & Forecast, Major Company of
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Alzheimer?s Disease Drug Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Alzheimer?s Disease Drug Market by Type
    
    2.1 By Type
    
       2.1.1 Donepezil
    
       2.1.2 Memantine
    
       2.1.3 Rivastigmine
    
    2.2
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -